Keywords
Last Name
Institution

Brian Sherman

Title
InstitutionMedical University of South Carolina
DepartmentPsychiatry and Behavioral Sciences
AddressP.O. Box MSC 861
Suite 190
125 Doughty - 125 Doughty St.
Phone843-792-8174
Fax843-792-4817
vCardDownload vCard

    Collapse Overview 
    Collapse keywords
    Substance Use, Psychiatry, Drug Studies

    Collapse ORNG Applications 
    Collapse studies/trials

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Joseph JE, McRae-Clark A, Sherman BJ, Baker NL, Moran-Santa Maria M, Brady KT. Neural correlates of oxytocin and cue reactivity in cocaine-dependent men and women with and without childhood trauma. Psychopharmacology (Berl). 2019 Nov 07. PMID: 31701163.
      View in: PubMed
    2. Campbell L, Galuska C, McRae-Clark A, Sherman B. Cortisol reactivity and situational drug use in cocaine-dependent females. Psychiatry Res. 2019 12; 282:112611. PMID: 31634766.
      View in: PubMed
    3. Sahlem GL, Caruso MA, Short EB, Fox JB, Sherman BJ, Manett AJ, Malcolm RJ, George MS, McRae-Clark AL. A case series exploring the effect of twenty sessions of repetitive transcranial magnetic stimulation (rTMS) on cannabis use and craving. Brain Stimul. 2020 Jan - Feb; 13(1):265-266. PMID: 31619347.
      View in: PubMed
    4. Joseph JE, Vaughan BK, Camp CC, Baker NL, Sherman BJ, Moran-Santa Maria M, McRae-Clark A, Brady KT. Oxytocin-Induced Changes in Intrinsic Network Connectivity in Cocaine Use Disorder: Modulation by Gender, Childhood Trauma, and Years of Use. Front Psychiatry. 2019; 10:502. PMID: 31379621.
      View in: PubMed
    5. Sherman BJ, Caruso MA, McRae-Clark AL. Exogenous progesterone for cannabis withdrawal in women: Feasibility trial of a novel multimodal methodology. Pharmacol Biochem Behav. 2019 04; 179:22-26. PMID: 30711528.
      View in: PubMed
    6. Sahlem GL, Tomko RL, Sherman BJ, Gray KM, McRae-Clark AL. Impact of cannabis legalization on treatment and research priorities for cannabis use disorder. Int Rev Psychiatry. 2018 06; 30(3):216-225. PMID: 29956576.
      View in: PubMed
    7. Baker NL, Gray KM, Sherman BJ, Morella K, Sahlem GL, Wagner AM, McRae-Clark AL. Biological correlates of self-reported new and continued abstinence in cannabis cessation treatment clinical trials. Drug Alcohol Depend. 2018 06 01; 187:270-277. PMID: 29698894.
      View in: PubMed
    8. Chauchard E, Hartwell KJ, McRae-Clark AL, Sherman BJ, Gorelick DA. Cannabis Withdrawal in Adults With Attention-Deficit/Hyperactivity Disorder. Prim Care Companion CNS Disord. 2018 Feb 22; 20(1). PMID: 29489073.
      View in: PubMed
    9. Sherman BJ, Baker NL, Squeglia LM, McRae-Clark AL. Approach bias modification for cannabis use disorder: A proof-of-principle study. J Subst Abuse Treat. 2018 04; 87:16-22. PMID: 29471922.
      View in: PubMed
    10. Moran-Santa Maria MM, Sherman BJ, Brady KT, Baker NL, Hyer JM, Ferland C, McRae-Clark AL. Impact of endogenous progesterone on reactivity to yohimbine and cocaine cues in cocaine-dependent women. Pharmacol Biochem Behav. 2018 02; 165:63-69. PMID: 29126857.
      View in: PubMed
    11. Tomko RL, Baker NL, McClure EA, Sonne SC, McRae-Clark AL, Sherman BJ, Gray KM. Incremental validity of estimated cannabis grams as a predictor of problems and cannabinoid biomarkers: Evidence from a clinical trial. Drug Alcohol Depend. 2018 01 01; 182:1-7. PMID: 29112827.
      View in: PubMed
    12. Sherman BJ, McRae-Clark AL, Baker NL, Sonne SC, Killeen TK, Cloud K, Gray KM. Gender differences among treatment-seeking adults with cannabis use disorder: Clinical profiles of women and men enrolled in the achieving cannabis cessation-evaluating N-acetylcysteine treatment (ACCENT) study. Am J Addict. 2017 Mar; 26(2):136-144. PMID: 28152236.
      View in: PubMed
    13. Sherman BJ, Baker NL, McRae-Clark AL. Effect of oxytocin pretreatment on cannabis outcomes in a brief motivational intervention. Psychiatry Res. 2017 Mar; 249:318-320. PMID: 28152465.
      View in: PubMed
    14. Sherman BJ, McRae-Clark AL. Treatment of Cannabis Use Disorder: Current Science and Future Outlook. Pharmacotherapy. 2016 05; 36(5):511-35. PMID: 27027272.
      View in: PubMed
    15. Sherman BJ, Baker NL, McRae-Clark AL. Gender differences in cannabis use disorder treatment: Change readiness and taking steps predict worse cannabis outcomes for women. Addict Behav. 2016 09; 60:197-202. PMID: 27156221.
      View in: PubMed
    16. Sherman BJ, Vousoura E, Wickramaratne P, Warner V, Verdeli H. Temperament and major depression: How does difficult temperament affect frequency, severity, and duration of major depressive episodes among offspring of parents with or without depression? J Affect Disord. 2016 Aug; 200:82-8. PMID: 27130957.
      View in: PubMed
    Sherman's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description